Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Positive order intake for Obducat - one of which involves a Sindre™ production system

Abstract:
Obducat has received two orders for its NIL systems from the Far East. One of these orders concerns the Sindre™ 60 system, which was recently launched. The customer is a world leading player in its industry, and the Sindre™ 60 system will be employed in commercial production. The second order, an Eitre™ 6 system, was placed by a well-reputed national R&D institute. Total order value for these NIL systems amounts to about SEK 9 million.

Positive order intake for Obducat - one of which involves a Sindre™ production system

Sweden | Posted on June 21st, 2007

The deal for Sindre™ 60 includes a license agreement for the patented technology on which the Obducat NIL technology is based. The customer having ordered the Sindre™ 60 system has the option to purchase a further system and the potential order value is about SEK 7 million.

The wholly-owned subsidiary Obducat CamScan Ltd. has won three new orders for high tech SEM (Scanning Electron Microscopes). The deal is valued at about SEK 7 million. One of the orders is subject to approval by British authorities.

"We are of course very pleased about these commercially important steps forward. With the order for a Sindre™ system, there are now two players, leading in their sphere, utilising our technology for production of commercial products. The expanded product capacity enables the customer to secure delivery to a greater number of end users, and to accomplish increased component volumes by implementing them in new applications. We also have a very positive view of the progress in our Obducat CamScan subsidiary, where the products now sold indeed constitute "high-end" products," says Patrik Lundström, CEO, Obducat AB.

####

About Obducat
Obducat AB is an innovative developer and supplier of technologies, products and processes used for the production and replication of advanced micro- and nano structures. Obducat´s products and services are intended to serve the demands of companies within the information storage, semiconductor, printed circuit board, and sensor industries. Obducat´s technologies include electron beam, and nano imprint technology. Obducat has offices in Sweden, and the UK, with the head quarter located in Malmö, Sweden. The Obducat shares are publicly traded on the Swedish NGM stock exchange.

For more information, please click here

Contacts:
Henri Bergstrand
Chairman of the Board
+46 (0)708 – 88 72 45

Patrik Lundström
CEO
+46 (0)40 – 36 21 00
+46 (0)703 – 27 37 38

Copyright © Obducat

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

New-Contracts/Sales/Customers

Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020

GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project